SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?


To: Charles Salski who wrote (759)5/19/1998 6:19:00 PM
From: Obelix  Read Replies (1) | Respond to of 1185
 
Charles,
I appreciate your research. This stock appears to be headed more south again, as per the normal VSE stock. This company will get some serious interest from institutional buyers once it is on the TSE or NASDAQ. I've noticed that most small cap and even micro cap mutual funds have a criteria of companies they invest in have to show growth potential, good management and be on the TSE.
I really think this should be NRT's next task.

Just my 2 cents...

Obee...